Eli Lilly
- August 9th, 2024
You’ve Lost Weight Taking New Obesity Drugs. What Happens if You Stop? – MASHAHER
- August 6th, 2024
This Will Be the Best Pharmaceutical Stock to Own Over the Next 10 Years – MASHAHER
- July 28th, 2024
Eli Lilly loses $120B in value over Viking’s GLP-1 progress – MASHAHER
- July 28th, 2024
These 2 Growth Stocks Are Set to Soar This Summer and Beyond – MASHAHER
- July 16th, 2024
2 Unstoppable Growth Stocks to Buy and Hold for the Next Decade – MASHAHER
- July 15th, 2024
2 Healthcare Stocks That Look Ready to Split – MASHAHER
- July 14th, 2024
2 High-Flying Growth Stocks You Can Buy Right Now Before They Surge Even Higher – MASHAHER
- July 2nd, 2024
FDA approves new Alzheimer’s treatment, donanemab from Eli Lilly – MASHAHER
- June 22nd, 2024
Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead – MASHAHER
- June 16th, 2024
Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster – MASHAHER
- June 15th, 2024
Top Stock Reports for Berkshire Hathaway, Eli Lilly & PepsiCo – MASHAHER
- June 7th, 2024
Is This Trend a Threat to Eli Lilly’s Weight Loss Drug Dominance? – MASHAHER
No more posts
No more posts